CDH2 and prostate cancer: Since prostate cancer metastasis involves EMT [11, 12], we investigated whether mtPC3 cells underwent EMT by assessing protein levels of epithelial (E-cadherin and β-catenin) and mesenchymal (N-cadherin, snail2, and vimentin) markers.